Autologous t-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: Rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies

Guardado en:
Detalles Bibliográficos
Autores principales: Elías, E.E., Almejún, M.B., Colado, A., Cordini, G., Vergara-Rubio, M., Podaza, E., Risnik, D., Cabrejo, M., Fernández-Grecco, H., Bezares, R.F., Custidiano, M.R., Sánchez-Ávalos, J.C., Vicente, Á., Garate, C.M., Borge, M., Giordano, M., Gamberale, R.
Formato: JOUR
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_03906078_v103_n10_pe458_Elias
Aporte de:
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires
id todo:paper_03906078_v103_n10_pe458_Elias
record_format dspace
spelling todo:paper_03906078_v103_n10_pe458_Elias2023-10-03T15:33:46Z Autologous t-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: Rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies Elías, E.E. Almejún, M.B. Colado, A. Cordini, G. Vergara-Rubio, M. Podaza, E. Risnik, D. Cabrejo, M. Fernández-Grecco, H. Bezares, R.F. Custidiano, M.R. Sánchez-Ávalos, J.C. Vicente, Á. Garate, C.M. Borge, M. Giordano, M. Gamberale, R. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_03906078_v103_n10_pe458_Elias
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
format JOUR
author Elías, E.E.
Almejún, M.B.
Colado, A.
Cordini, G.
Vergara-Rubio, M.
Podaza, E.
Risnik, D.
Cabrejo, M.
Fernández-Grecco, H.
Bezares, R.F.
Custidiano, M.R.
Sánchez-Ávalos, J.C.
Vicente, Á.
Garate, C.M.
Borge, M.
Giordano, M.
Gamberale, R.
spellingShingle Elías, E.E.
Almejún, M.B.
Colado, A.
Cordini, G.
Vergara-Rubio, M.
Podaza, E.
Risnik, D.
Cabrejo, M.
Fernández-Grecco, H.
Bezares, R.F.
Custidiano, M.R.
Sánchez-Ávalos, J.C.
Vicente, Á.
Garate, C.M.
Borge, M.
Giordano, M.
Gamberale, R.
Autologous t-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: Rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies
author_facet Elías, E.E.
Almejún, M.B.
Colado, A.
Cordini, G.
Vergara-Rubio, M.
Podaza, E.
Risnik, D.
Cabrejo, M.
Fernández-Grecco, H.
Bezares, R.F.
Custidiano, M.R.
Sánchez-Ávalos, J.C.
Vicente, Á.
Garate, C.M.
Borge, M.
Giordano, M.
Gamberale, R.
author_sort Elías, E.E.
title Autologous t-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: Rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies
title_short Autologous t-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: Rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies
title_full Autologous t-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: Rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies
title_fullStr Autologous t-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: Rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies
title_full_unstemmed Autologous t-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: Rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies
title_sort autologous t-cell activation fosters abt-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with syk inhibitors and anti-cd20 monoclonal antibodies
url http://hdl.handle.net/20.500.12110/paper_03906078_v103_n10_pe458_Elias
work_keys_str_mv AT eliasee autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT almejunmb autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT coladoa autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT cordinig autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT vergararubiom autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT podazae autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT risnikd autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT cabrejom autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT fernandezgreccoh autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT bezaresrf autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT custidianomr autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT sanchezavalosjc autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT vicentea autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT garatecm autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT borgem autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT giordanom autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
AT gamberaler autologoustcellactivationfostersabt199resistanceinchroniclymphocyticleukemiarationaleforacombinedtherapywithsykinhibitorsandanticd20monoclonalantibodies
_version_ 1782029844405551104

Ejemplares similares